NCT00431496View on ClinicalTrials.gov

A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

October 31, 2009

Conditions
AnemiaSecondary Hyperparathyroidism
Interventions
DRUG

Cinacalcet

Cinacalcet tablets

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00431496 - A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD) | Biotech Hunter | Biotech Hunter